Molecular markers in gliomas: Impact for the clinician Journal Article


Authors: Hofer, S.; Lassman, A. B.
Article Title: Molecular markers in gliomas: Impact for the clinician
Abstract: Over the last decade, understanding of glioma on a molecular level has greatly expanded. However, optimal incorporation of molecular markers into clinical care is controversial. We briefly review the potential utility of molecular stratification in refining histologic diagnosis, prognosis, and treatment decisions, focussing on 1p/19q co-deletion, MGMT promoter methylation, EGFR mutations, and IDH mutation. The most recently discovered IDH mutation is a striking example of a rapid implementation of a molecular marker for prognostication into common clinical use. © 2010 Springer-Verlag.
Keywords: cancer survival; protein expression; treatment outcome; unclassified drug; gene mutation; overall survival; promoter region; clinical trial; histopathology; review; erlotinib; drug dose comparison; antineoplastic agents; adjuvant therapy; cancer radiotherapy; disease free survival; temozolomide; glioma; brain neoplasms; medical decision making; epidermal growth factor receptor; neoplasm proteins; tumor markers, biological; vincristine; dna methylation; lomustine; procarbazine; molecular marker; dna; diagnostic value; glioblastoma; phosphatidylinositol 3,4,5 trisphosphate 3 phosphatase; gefitinib; intermethod comparison; pharmacogenetics; methylated dna protein cysteine methyltransferase; egfr; chromosome deletion; chromosome 1p; isocitrate dehydrogenase; molecular; idh; isocitrate dehydrogenase 1; isocitrate dehydrogenase isoenzyme; 1p19q; mgmt; predictive; prognostic; chromosome 19q
Journal Title: Targeted Oncology
Volume: 5
Issue: 3
ISSN: 1776-2596
Publisher: Springer  
Date Published: 2010-09-01
Start Page: 201
End Page: 210
Language: English
DOI: 10.1007/s11523-010-0157-2
PUBMED: 20809335
PROVIDER: scopus
DOI/URL:
Notes: --- - "Export Date: 20 April 2011" - "Source: Scopus"
Altmetric
Citation Impact
BMJ Impact Analytics
MSK Authors
  1. Andrew Lassman
    111 Lassman